로딩 중…
지수 로딩 중…
BioNote, Inc.
377740· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩4,640+0.22%
2026-06-19
Price Chart
BioNote, Inc.-9.90%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 472.75B KRW |
| Revenue | 122.44B KRW |
| Net Income | -50.23B KRW |
| Total Assets | 1.61T KRW |
| Net Assets | 1.54T KRW |
| Employees | 313 |
| Value | |
| P/B | 0.31x |
| P/S | 3.86x |
| EV/EBITDA | 167.68x |
| FCF Yield | 1.33% |
| Profitability | |
| ROE | -3.26% |
| ROA | -3.12% |
| Op. Margin | 2.03% |
| Revenue Growth | 14.49% |
| Earnings Growth | 925.36% |
| Financial Health | |
| Debt Ratio | 104.40% |
| Total Debt | 0 KRW |
| FCF | 6.27B KRW |
| Cash | 55.08B KRW |
| Current Ratio | 10.15x |
| Net Debt/EBITDA | -22.11x |
| Dividend | |
| Div. Yield | 4.92% |
| Div. Growth | 14.00% |
| Performance | |
| 1Y Return | -9.90% |
| 1M Return | -7.11% |
| From 52W High | -26.58% |
| 1Y MDD | -27.45% |
| Trading | |
| Volume | 77,830 shares |
| Foreign Own. | 0.48% |
| Per Share | |
| EPS | -492 KRW |
| BPS | 15,288 KRW |
Company Info
Bionote, established in 2003 and listed on the KOSPI market in 2022, specializes in animal diagnostic products and bio-content. Utilizing its unique recombinant antigen and antibody manufacturing technology, it produces and distributes diverse diagnostic products and bio-content across over 80 countries. The company is expanding its business into molecular and biochemical diagnostics. It aims to increase global market share by launching fully automated point-of-care diagnostic devices.